# Rezdiffra Pregnancy and Lactation Registry

> **NCT07541469** · — · RECRUITING · sponsor: **Madrigal Pharmaceuticals, Inc.** · enrollment: 10 (estimated)

## Conditions studied

- MASH - Metabolic Dysfunction-Associated Steatohepatitis

## Interventions

- **DRUG:** Rezdiffra

## Key facts

- **NCT ID:** NCT07541469
- **Lead sponsor:** Madrigal Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-04
- **Primary completion:** 2030-04-08
- **Final completion:** 2030-04-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07541469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07541469, "Rezdiffra Pregnancy and Lactation Registry". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07541469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*